News

A fixed-dose inhaled corticosteroid/long-acting β 2-agonist (ICS/LABA) combination of extrafine beclometasone dipropionate and formoterol fumarate (BDP/FF) has been ...
The inhalers contained ICS (beclometasone dipropionate 100 μg) and LABA (formoterol fumarate 6 μg). Half of the inhalers also contained long-acting muscarinic antagonist glycopyrronium 10 μg In ...
In TRIMARAN, patients were randomly assigned to two inhalations twice daily from a single inhaler, for 52 weeks, of beclometasone dipropionate 100 μg plus formoterol fumarate 6 μg with or ...
and colleagues conducted a multicenter double-blind study to compare the efficacy and safety of an extrafine combination inhaler of beclometasone plus formoterol (852 patients) with salbutamol ...
Luforbec ® 100/6 (beclometasone 100mcg / formoterol 6mcg) pMDI, first branded generic alternative to Fostair ® 100/6 pMDI to treat Asthma & COPD, is now available in the UK Lupin continues their ...
Lupin Healthcare announces availability of the first carbon neutral pMDI with Luforbec ® 100/6 (beclometasone 100 mcg / formoterol 6 mcg) and establishes their commitment to supporting the NHS green ...
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for Trimbow (Chiesi Farmaceutici S.p.A., Italy), a ...
4.1 Clinical effectiveness 4.1.1 There is a large body of evidence for the use of ICSs in asthma, with studies of various methodologies reported in the literature as well as unpublished studies ...
We would like to raise concerns regarding significant deficiencies in the article ‘Evidence-based asthma care', a reproduction of a review by Map of Medicine, which ...
3.2 Beclometasone dipropionate is licensed for use in children ... Budesonide is available in combination with formoterol fumarate in a DPI (Symbicort Turbohaler, AstraZeneca), and fluticasone ...
Patients were randomly assigned to one of three regimens: twice-daily placebo plus terbutaline (0.5 mg) used as needed (terbutaline group), twice-daily placebo plus budesonide–formoterol (200 ...